Search Results Search Sort by RelevanceMost Recent Medicine and Society Feb 2021 How Can the Experiences of Black Women Living With HIV Inform Equitable and Respectful Reproductive Health Care Delivery? Faith E. Fletcher, PhD, MA, Ndidiamaka Amutah-Onukagha, PhD, MPH, Julie Attys, MPH, and Whitney S. Rice, DrPH, MPH Black women living with HIV contend with injuries of injustice that influence their reproductive lives. AMA J Ethics. 2021;23(2):E156-165. doi: 10.1001/amajethics.2021.156. History of Medicine Sep 2021 FDA Device Oversight From 1906 to the Present Anna Pisac and Natalia Wilson, MD, MPH A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices. AMA J Ethics. 2021;23(9):E712-720. doi: 10.1001/amajethics.2021.712. Viewpoint Sep 2021 Is the FDA Failing Women? Madris Kinard, MBA and Rita F. Redberg, MD, MSc Many devices in current use were marketed before manufacturers were required to demonstrate safety and effectiveness. AMA J Ethics. 2021;23(9):E750-756. doi: 10.1001/amajethics.2021.750.
Medicine and Society Feb 2021 How Can the Experiences of Black Women Living With HIV Inform Equitable and Respectful Reproductive Health Care Delivery? Faith E. Fletcher, PhD, MA, Ndidiamaka Amutah-Onukagha, PhD, MPH, Julie Attys, MPH, and Whitney S. Rice, DrPH, MPH Black women living with HIV contend with injuries of injustice that influence their reproductive lives. AMA J Ethics. 2021;23(2):E156-165. doi: 10.1001/amajethics.2021.156.
History of Medicine Sep 2021 FDA Device Oversight From 1906 to the Present Anna Pisac and Natalia Wilson, MD, MPH A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices. AMA J Ethics. 2021;23(9):E712-720. doi: 10.1001/amajethics.2021.712.
Viewpoint Sep 2021 Is the FDA Failing Women? Madris Kinard, MBA and Rita F. Redberg, MD, MSc Many devices in current use were marketed before manufacturers were required to demonstrate safety and effectiveness. AMA J Ethics. 2021;23(9):E750-756. doi: 10.1001/amajethics.2021.750.